Guardant Health Asia, Middle East & Africa (AMEA) is a joint venture between SoftBank and Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics.
The global cancer burden is estimated to have risen to 18.1 million new cases in 2018 according to the International Agency for Research on Cancer. Asia accounts for nearly half of the new cancer cases worldwide. The Middle East accounts for approximately 0.25 million new cancer cases while Africa accounts for over 1 million new cancer cases. Guardant Health AMEA was formed to address the growing cancer burden in Asia, Middle East, and Africa.
To select the best treatment, doctors and patients must have access to detailed genomic information about the disease. But this information is not easy to obtain. Traditional tissue biopsies require physical access to tumor tissue and come with serious risks for some patients. And for many patients, they aren’t even an option.
We believe the key to conquering cancer is unprecedented access to its molecular information throughout all stages of the disease. We are developing a solution through tests that require only a blood sample.
Today, Guardant’s blood tests are enabling timely therapy selection for patients with cancer while we also advance programs for recurrence detection and early cancer detection. In addition, we are working together with pharmaceutical companies to discover and understand new treatment approaches that lead to better outcomes for patients.
We are driven by an intense passion to dramatically change the course of the patient journey. Our frustration with the data-starved status quo and our strong desire to improve human health shapes our unique culture.
Uphold integrity.
We are honest and sincere in the work we do.
Put the patient first.
We imagine all patients as our own family members.
Be bold and original.
Blindly following status quo rarely leads to breakthrough innovations.
Move fast without compromising quality.
Every minute we waste means falling behind cancer’s relentless march.
Value Teamwork.
Valuing everyone’s contribution is the secret to our success.
Cancer affects millions, but at Guardant Health AMEA, you will focus on the individual and be asked to imagine each patient as a member of your own family.
You will work with a mix of top scientists, engineers, clinicians, commercial experts, reimbursement specialists, and many more talented individuals.
When you join us, you become an integral part of the team, contributing your unique skills and talents to solve some of the most challenging and complex problems in healthcare.
We prioritize our people and provide rewarding careers for the intellectually curious and unabashedly determined. Are you ready to make a difference?
Address:
3 Fusionopolis Link, # 02-11,
Nexus @ One-North,
Singapore 138543.
Telephone:
+65 63056523 / +65 63056520
WhatsApp Hotline:
+65 8940 0360
Email:
Media inquiries:
Guardant Health Japan Corp.
Address:
27F Shiodome Sumitomo Bldg.,
1-9-2 Higashi-shimbashi, Minato-ku,
Tokyo, 105-0021, Japan.
Email:
© 2019 Guardant Health AMEA ALL RIGHTS RESERVED
